Presentation is loading. Please wait.

Presentation is loading. Please wait.

Suppression of ENTPD5 in human NSCLC cells results in decreased AKT activity and decreased proliferation under low-serum conditions. Suppression of ENTPD5.

Published byMargaret Ray Modified over 5 years ago

Similar presentations

Presentation on theme: "Suppression of ENTPD5 in human NSCLC cells results in decreased AKT activity and decreased proliferation under low-serum conditions. Suppression of ENTPD5."— Presentation transcript:

1 Suppression of ENTPD5 in human NSCLC cells results in decreased AKT activity and decreased proliferation under low-serum conditions. Suppression of ENTPD5 in human NSCLC cells results in decreased AKT activity and decreased proliferation under low-serum conditions. A and D, levels of ENTPD5, IGF-IRβ, phospho-S473 AKT (p-AKT; high and low exposures), total AKT, PTEN, and GAPDH in A549 and NCI-H23 human NSCLC cell lines (A), or in NCI-H23 cells with stable knockdown of GFP or ENTPD5 (shE5-a; D), grown in media supplemented with 10% serum or 0% serum for 1 or 24 hours. B and E, graphs representing quantified changes (obtained by ImageJ) in ENTPD5, IGF-IRβ or PTEN, over GAPDH protein levels or p-AKT/AKT, assayed for in A or D, respectively. C and F, proliferation curves of A549 and NCI-H23 (C), described in A or NCI-H23-shGFP, NCI-H23-shE5-a cell lines (F), described in D, grown in the presence of 0.1% serum supplemented with increasing concentrations of insulin or IGF-I for 7 days (n = 6). **, P < 0.01; ****, P < (ANOVA/Bonferroni tests for differences between 1 ng/mL insulin or 0.5 ng/mL IGF-I and all other conditions at day 7 in C and F). In A, separated lanes of the ENTPD5 blot were acquired from a single electrophoresis gel. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Natasha L. Curry et al. Cancer Discovery 2013;3: ©2013 by American Association for Cancer Research

Download ppt "Suppression of ENTPD5 in human NSCLC cells results in decreased AKT activity and decreased proliferation under low-serum conditions. Suppression of ENTPD5."

Similar presentations

Figure 1. Interaction of FKBP51 with GRα and PPARγ

Figure 1. Interaction of FKBP51 with GRα and PPARγ
Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3 Cell Physiol Biochem 2016;40:1221-1229.

Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3 Cell Physiol Biochem 2016;40:
The Fumagillin Analogue TNP-470 Inhibits DNA Synthesis of Vascular Smooth Muscle Cells Stimulated by Platelet-Derived Growth Factor and Insulin-like Growth.

The Fumagillin Analogue TNP-470 Inhibits DNA Synthesis of Vascular Smooth Muscle Cells Stimulated by Platelet-Derived Growth Factor and Insulin-like Growth.
KG-501 suppresses NSCLC/IL-1β CM–induced migration of HUVECs by regulating IL-1β–induced CXC chemokine gene expression in NSCLC cells. KG-501 suppresses.

KG-501 suppresses NSCLC/IL-1β CM–induced migration of HUVECs by regulating IL-1β–induced CXC chemokine gene expression in NSCLC cells. KG-501 suppresses.
SCLCs and LCNECs are sensitive to PARP inhibition in vitro.

SCLCs and LCNECs are sensitive to PARP inhibition in vitro.
CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.

CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.
IL-1β differentially regulates CXCL5 and CXCL8 protein secretion in NHTBE and NSCLC cells. IL-1β differentially regulates CXCL5 and CXCL8 protein secretion.

IL-1β differentially regulates CXCL5 and CXCL8 protein secretion in NHTBE and NSCLC cells. IL-1β differentially regulates CXCL5 and CXCL8 protein secretion.
Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease  Sandhya S. Thomas, Yanjun Dong,

Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease  Sandhya S. Thomas, Yanjun Dong,
Antiproliferative effects of erlotinib correlate poorly with abundance of p-EGFR. Antiproliferative effects of erlotinib correlate poorly with abundance.

Antiproliferative effects of erlotinib correlate poorly with abundance of p-EGFR. Antiproliferative effects of erlotinib correlate poorly with abundance.
Small-molecule inhibitor QLT-0267 suppresses ILK activity and inhibits its downstream signaling. Small-molecule inhibitor QLT-0267 suppresses ILK activity.

Small-molecule inhibitor QLT-0267 suppresses ILK activity and inhibits its downstream signaling. Small-molecule inhibitor QLT-0267 suppresses ILK activity.
Resistin decreases insulin-like growth factor I–induced steroid production and insulin- like growth factor I receptor signaling in human granulosa cells 

Resistin decreases insulin-like growth factor I–induced steroid production and insulin- like growth factor I receptor signaling in human granulosa cells 
NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.

NF1 silencing confers resistance of PC9 lung adenocarcinoma cells to erlotinib (erl). NF1 silencing confers resistance of PC9 lung adenocarcinoma cells.
Recombinant OPCML protein effect in vitro.

Recombinant OPCML protein effect in vitro.
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.

Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
DNAPKcs is required for DNA repair in the presence of androgen.

DNAPKcs is required for DNA repair in the presence of androgen.
Andreea M. Bujor, Jaspreet Pannu, Shizhong Bu, Edwin A. Smith, Robin C

Andreea M. Bujor, Jaspreet Pannu, Shizhong Bu, Edwin A. Smith, Robin C
NRP2 represses IGF-IR expression and signaling.

NRP2 represses IGF-IR expression and signaling.
Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non–Small- Cell Lung Cancer  Yuhchyau Chen, MD, PhD, Irena Nowak, PhD, Jiaoti Huang,

Erk/MAP Kinase Signaling Pathway and Neuroendocrine Differentiation of Non–Small- Cell Lung Cancer  Yuhchyau Chen, MD, PhD, Irena Nowak, PhD, Jiaoti Huang,
TRAIL-induced formation from the preligand assembly complex to the DISC. A, normal brain and glioblastoma tissues were examined by immunoblotting using.

TRAIL-induced formation from the preligand assembly complex to the DISC. A, normal brain and glioblastoma tissues were examined by immunoblotting using.
The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma cells. The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma.

The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma cells. The EGF receptor confers BRAF inhibitor resistance in BRAF-mutant melanoma.

Similar presentations

Ads by Google